Please assess the completion status of the following clinical trial:

Trial Title: Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with bipolar I disorder in partial or full remission and deemed clinically stable~Exclusion Criteria:~* Current use of benzodiazepines, prescription or herbal sleep agents~* Use of antihistamines~* Use of antipsychotic medications in the past 6 months~* Pregnant/breastfeeding females~* Females not using contraception~* Illicit drug users

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).